Aspira Pathlab & Diagnostics Ltd

Know More
NSEBSE
Stock not tradded

33.91-0.09 (-0.26%)

12:00 AM,23rd Feb 2024

BSE : 540788

NSE :

Sector : Health care

ISIN Code : INE500C01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 23 2024 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd 1973. The Company is engaged into the business of running owning managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs. 7/- per share) on preferential basis to promoters & group of strategic investors not forming part of the promoter. The allotment was made on 19th November 2016 & listing & trading approval is awaited. The paid-up capital as on 31st March 2017 was 5193000 equity shares of Rs. 10/- each.The Company has changed its object clause on 10th August 2016; its present name was changed on 16th November 2016 & registered office of the company was shifted from State of West Bengal to State of Maharashtra vide order dated 18th November 2016 & company again shifted its registered office within the city limit of Mumbai on 17th March 2017.During the year 2017 the Company applied to BSE Limited on 27th July 2017 under Direct Listing norms of BSE Limited for listing & trading of its securities at BSE Limited.During the year 2018-19 issued subscribed and paid- up capital of the of the Company has increased from 51930000 to Rs. 136930000/- divided into 8193000 Equity Shares of Rs. 10/- each and 5500000 9% Non-Cumulative Non-convertible Non-Participating Redeemable Preference Shares of Rs. 10/- each.The Company got delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited w.e.f. April 12th 2018 and October 15th 2018 respectively.

Aspira Pathlab & Diagnostics Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

34

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

3.08

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]11.00
P/B Ratio (₹) [S]3.08
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

31.20

34.79

Week Low/High

31.20

38.00

Month Low/High

30.00

38.00

Year Low/High

22.76

50.00

All time Low/High

14.15

124.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.53%%1.290.78%
1 Month-5.67%%4.244.59%
3 Month-15.01%%11.1212.17%
6 Month-15.08%%12.1114.24%
1 Year-5.28%%23.0726.85%
3 Year%%47.4551.03%

Company Info

Company Information

Managing Director & CEO : Pankaj Jashwant Shah

Non Executive Director : Arvind Karsandas Bhanushali

Independent Director : Mangala Radha Krishnan Prabhu

Chairman & Independent Directo : Haseeb Drabu

Non Executive Director : Nikunj Mange

Independent Director : Subhash Raghunath Salunke

Independent Director : A C Mahajan

Independent Director : Manas Mengar

Registered Office: Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W),Mumbai,Maharashtra-400086 Ph: 91-22-71975756/5656

Email:info@aspiradiagnostics.com/urkalsoaps@gmail.com

URL:http://www.aspiradiagnostics.com